Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA1S8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,620
Award facts
- Contract value 100% obligated
- $24,620.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $24,620.02 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This award, issued on January 7, 2026, with an ultimate completion date of January 8, 2026, represents a non-set-aside competitive award. The pharmaceutical products will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., the parent company and primary pharmaceutical distributor serving the Department of Defense and military healthcare systems.
AmerisourceBergen's extensive contract portfolio with the DLA demonstrates its critical role in supporting military and federal healthcare operations through the supply of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The company's capability to compete successfully on a full and open basis, combined with its established infrastructure as a prime vendor in the federal pharmaceutical supply chain, positions it as a key supplier for prescription medications including diabetes treatments like Ozempic that are essential to military medical readiness and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FA1S8?
SPE2DR26FA1S8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FA1S8 worth?
The government has obligated $24,620 on SPE2DR26FA1S8.
Is contract SPE2DR26FA1S8 an order under another contract?
Yes. SPE2DR26FA1S8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1S8 competed?
The extent of competition for SPE2DR26FA1S8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award